Poster Board I-171 Background: Nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation (HCT) has been increasingly used as treatment for elderly patients with hematologic malignancies. It has
. Evolution of sjTREC concentration according to patient age at HCT.
CD4+CD45RA+) counts (P<0.0001
). An inverse correlation was observed between the levels of sjTREC/ml and the recipient's age (R=-0.41, p<0.0001). Interestingly, sjTREC levels increased from day 100 to 1 and 2 years after transplantation in patients 50 (n=23; P=0.02 and P=0.04, respectively), and in those 51-60 years of age (n=35; P=0.17 and P=0.06, respectively), but not in patients >60 (n=22; P=0.3 and P=0.3, respectively) ( Figure 1) . Similarly, naïve CD4 T cell counts increased from day 100 to 1 and 2 years after transplantation in patients 50 (n=23; P=0.01 and P=0.3, respectively), and in those 51-60 years of age (n=35; P=0.5 and P<0.001, respectively), but not in patients >60 (n=22; P=0.9 and P=1.0, respectively). In multivariate analyses, older patient age (P<0.001), extensive chronic GVHD (P<0.001), and prior (resolved) extensive chronic GVHD (P=0.008) were associated with low sjTREC levels, while older patient age (P<0.001), and extensive chronic GVHD (P<0.001) were associated with low naïve CD4 T cell counts.
Conclusions:
Our data suggest that thymic neo-generation of T cells occurred from day 100 onwards in patients under 60. However, the levels of sjTREC remained low for patients above 60. Further, chronic GVHD has a dramatic impact on thymic function, as observed after myeloablative conditioning. 
